Compare Ginkgo Bioworks Holdings Inc (DNA) vs Rent the Runway Inc (RENT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ginkgo Bioworks Holdings Inc vs Rent the Runway Inc — how do they compare? Ginkgo Bioworks Holdings Inc trades at $13 (market cap $763.64M), while Rent the Runway Inc trades at $1.77 (market cap $61.75M). The key difference: Ginkgo Bioworks Holdings Inc is far larger — about 12.4× Rent the Runway Inc's market cap, and Ginkgo Bioworks Holdings Inc is trading nearer its 52-week high, Rent the Runway Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Ginkgo Bioworks Holdings Inc for 7 Days and Rent the Runway Inc for 56 Days on average.
| DNA | RENT | |
|---|---|---|
Market Cap | $763.64M | $61.75M |
Volume | 3,204,177 | 193,323 |
Sector | Health | Consumer Cyclical |
52-Week High | $15.83 | $9.39 |
52-Week Low | $5.48 | $1.55 |
Typical Hold Time | 7 Days | 56 Days |
Enterprise Value | $865.59M | $228.75M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Ginkgo Bioworks (DNA) trades at $11.34, down 1.13% on the day, with a bullish technical signal from moving averages. The company reported a net loss of $312.76 million on $170.16 million revenue for 2025, with negative cash flow. Recent news includes a $17.5 million ARPA-H subcontract for RNA medicine manufacturing, highlighting ongoing strategic initiatives despite financial challenges.
The outlook remains speculative given persistent losses and cash burn, though analyst consensus is divided. Key risks include execution on revenue growth and path to profitability. Upside depends on successful commercialization of its biotech platform and partnerships, but high volatility and fundamental weakness warrant caution for investors.
Rent the Runway (RENT) trades at $1.83, up 8.93% today, with a bullish technical signal despite mixed moving averages and oscillators. The company reported Q2 2026 revenue growth of 20.8% year-over-year to $97.7 million, with improving gross margins, and appointed Paige Thomas as CEO. However, the stock faces negative shareholder equity of -$182.5 million and a high debt-to-asset ratio of 139.62% as of 2025, though 2026 projections show a return to net profitability.
The outlook is cautiously optimistic, with analyst consensus at 42.1% buy ratings and no sell ratings, but legal investigations and high leverage pose significant risks. Revenue growth and margin expansion are key catalysts, yet investor confidence is tempered by ongoing financial instability and negative equity.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →About Rent the Runway Inc
Rent the Runway Inc is an e-commerce platform that allows users to rent, subscribe, or buy designer apparel and accessories.
Read more on RENT →
